Skip to content

Quantification of Myocardial Blood Flow by Positron Emission Tomography in Healthy Volunteers

Quantification of Myocardial Blood Flow by Positron Emission Tomography in Healthy Volunteers

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03895554
Acronym
PET Normals
Enrollment
20
Registered
2019-03-29
Start date
2019-04-01
Completion date
2019-09-30
Last updated
2019-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Healthy Volunteers Without Chronic Medical Conditions

Brief summary

To establish quantitative values of myocardial blood flow (MBF) in normal, healthy volunteers .

Detailed description

We seek to establish quantitative values of myocardial blood flow in 20 normal, healthy volunteers using our existing 2D PET camera (Positron Attrius) and invasively validated software package (HeartSee) in order to 1) establish institutional values for which clinical patients can be compared to and 2) add to the collective data of the scientific community. Values to be measured will be resting myocardial blood flow (MBF), stress MBF and coronary flow reserve.

Interventions

PROCEDUREcardiac PET stress test

Volunteers will undergo cardiac PET stress testing

Sponsors

Ochsner Health System
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults ≥18 and \<40 years old * Participants must be able to give informed consent. * Ability to abstain from caffeine for 48 hours

Exclusion criteria

* Any chronic cardiac disease or condition (e.g. hypertension, hyperlipidemia) * Any chronic systemic disease or condition (e.g. diabetes, systemic lupus, rheumatoid arthritis) * Tobacco use * Family history in a first degree relative with clinical coronary artery disease (history of myocardial infarctio, percutaneous intervention or coronary artery bypass grafting) in men \<55 years old or women \<65 years old * Severe claustrophobia * Positive urine pregnancy test * Inability to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Absolute myocardial blood flow at rest and stress in cc/min/gmeasured at the time of the cardiac PET stress scanresting and stress MBF are in units of cc/min/g

Countries

United States

Contacts

Primary ContactRobert M Bober, MD
rbober@ochsner.org5048426821
Backup ContactHunter McDaniel
hunter.mcdaniel@ochsner.org5047033272

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026